<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1355" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1355/" /><meta name="ncbi_pagename" content="Myotonia Congenita - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Myotonia Congenita - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Myotonia Congenita" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/08/06" /><meta name="citation_author" content="Morten Dunø" /><meta name="citation_author" content="Eskild Colding-Jørgensen" /><meta name="citation_pmid" content="20301529" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1355/" /><meta name="citation_keywords" content="Thomsen Disease" /><meta name="citation_keywords" content="Becker Disease" /><meta name="citation_keywords" content="Chloride channel protein 1" /><meta name="citation_keywords" content="CLCN1" /><meta name="citation_keywords" content="Myotonia Congenita" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Myotonia Congenita" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Morten Dunø" /><meta name="DC.Contributor" content="Eskild Colding-Jørgensen" /><meta name="DC.Date" content="2015/08/06" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1355/" /><meta name="description" content="Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the &quot;warm-up&quot; phenomenon). Muscles are usually hypertrophic. The autosomal recessive form of myotonia congenita is often associated with more severe symptoms than the autosomal dominant form. Individuals with the autosomal recessive form may have progressive, minor distal weakness and attacks of transient weakness brought on by movement after rest. The age of onset is variable: in autosomal dominant myotonia congenita, onset of symptoms is usually in infancy or early childhood; in the autosomal recessive form, the average age of onset is slightly older. In both, onset may be as late as the third or fourth decade of life." /><meta name="og:title" content="Myotonia Congenita" /><meta name="og:type" content="book" /><meta name="og:description" content="Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the &quot;warm-up&quot; phenomenon). Muscles are usually hypertrophic. The autosomal recessive form of myotonia congenita is often associated with more severe symptoms than the autosomal dominant form. Individuals with the autosomal recessive form may have progressive, minor distal weakness and attacks of transient weakness brought on by movement after rest. The age of onset is variable: in autosomal dominant myotonia congenita, onset of symptoms is usually in infancy or early childhood; in the autosomal recessive form, the average age of onset is slightly older. In both, onset may be as late as the third or fourth decade of life." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1355/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/myotonia-c/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1355/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8912CAE04072910000000003620195.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1355_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1355_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mstn/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/myotonic-d/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1355_"><span class="title" itemprop="name">Myotonia Congenita</span></h1><p class="contrib-group"><span itemprop="author">Morten Dun&#x000f8;</span>, PhD and <span itemprop="author">Eskild Colding-J&#x000f8;rgensen</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1355_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1355_ai__"><div class="contrib half_rhythm"><span itemprop="author">Morten Dun&#x000f8;</span>, PhD<div class="affiliation small">Molecular Genetic Laboratory<br />Department of Clinical Genetics<br />University Hospital Copenhagen<br />Copenhagen, Denmark<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="kd.hr@eonudm" class="oemail">kd.hr@eonudm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Eskild Colding-J&#x000f8;rgensen</span>, MD<div class="affiliation small">Department of Neurology<br />Roskilde Hospital<br />University of Copenhagen<br />Copenhagen, Denmark<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="kd.dnalleajsnoiger@ocse" class="oemail">kd.dnalleajsnoiger@ocse</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 3, 2005</span>; Last Update: <span itemprop="dateModified">August 6, 2015</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="myotonia-c.Summary" itemprop="description"><h2 id="_myotonia-c_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the "warm-up" phenomenon). Muscles are usually hypertrophic. The <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form of myotonia congenita is often associated with more severe symptoms than the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> form. Individuals with the autosomal recessive form may have progressive, minor distal weakness and attacks of transient weakness brought on by movement after rest. The age of onset is variable: in autosomal dominant myotonia congenita, onset of symptoms is usually in infancy or early childhood; in the autosomal recessive form, the average age of onset is slightly older. In both, onset may be as late as the third or fourth decade of life.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Myotonia congenita is diagnosed clinically by the presence of episodes of myotonia beginning in early childhood, alleviation of stiffness by brief exercise, myotonic contraction elicited by percussion of muscles, electromyography revealing myotonic bursts, elevated serum creatine kinase concentration, and family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance. <i>CLCN1</i>, encoding a chloride channel, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with myotonia congenita. Sequence analysis of <i>CLCN1</i> detects more than 95% of pathogenic variants causing both the autosomal recessive and autosomal dominant forms of myotonia congenita.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Muscle stiffness may respond to sodium channel blockers such as mexiletine (currently the medication with best documented effect), carbamazepine, or phenytoin. Beneficial effects have also been reported with quinine, dantrolene, and acetazolamide.</p><p><i>Agents/circumstances to avoid:</i> Depolarizing muscle relaxants (e.g., suxamethonium), adrenaline, beta-adrenergic agonists, propranolol, and colchicine may aggravate myotonia.</p><p><i>Evaluation of relatives at risk:</i> Because individuals with myotonia congenita may be at increased risk for adverse anesthesia-related events, testing of at-risk individuals during childhood to clarify their genetic status is appropriate.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Myotonia congenita is inherited in either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (Becker disease) or an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (Thomsen disease); the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may occur in families with both types of inheritance. In the autosomal dominant form, the proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown; each child of an individual with autosomal dominant myotonia congenita has a 50% chance of inheriting the pathogenic variant. In autosomal recessive myotonia congenita, heterozygotes are usually asymptomatic; at conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Establishing the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) may not be possible unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> reveals two pathogenic variants in <i>CLCN1</i>, in which case inheritance can be assumed to be autosomal recessive. Testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant(s) in the family are known.</p></div></div><div id="myotonia-c.Diagnosis"><h2 id="_myotonia-c_Diagnosis_">Diagnosis</h2><div id="myotonia-c.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Myotonia congenita <b>should be suspected</b> in individuals with the following clinical and laboratory findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Episodes of muscle stiffness (myotonia) or cramps beginning in early childhood (Myotonia is defined as impaired relaxation of skeletal muscle after voluntary contraction.)</div></li><li class="half_rhythm"><div>Alleviation of stiffness by brief exercise (known as the "warm-up" effect)</div></li><li class="half_rhythm"><div>Myotonic contraction elicited by percussion of muscles</div></li><li class="half_rhythm"><div>Family history consistent with either <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance</div></li></ul><p><b>Laboratory findings</b></p><ul><li class="half_rhythm"><div><b>Serum creatine kinase concentration</b> that may be slightly elevated (&#x02264;3-4x the upper limits of normal)</div></li><li class="half_rhythm"><div><b>Electromyography (EMG)</b> performed with needle electrodes that discloses characteristic showers of spontaneous electrical activity (myotonic bursts)</div></li></ul><p>Note: Guidelines for <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> based on electrophysiologic tests in myotonic disorders have been formulated [<a class="bk_pop" href="#myotonia-c.REF.tan.2011">Tan et al 2011</a>] (<a href="http://onlinelibrary.wiley.com/doi/10.1002/ana.22238/pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>); however, in most cases the clinical features provide sufficient guidance.</p><p><b>Muscle biopsy</b> is usually normal, although absence of type 2B fibers is sometimes noted. In very severe cases of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita, myopathic changes may be found.</p><p>Note: Muscle biopsy is not required to consider or establish the diagnosis of myotonia congenita.</p></div><div id="myotonia-c.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of myotonia congenita <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CLCN1</i> (see <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figmyotoniacTmoleculargenetictestingu" rid-ob="figobmyotoniacTmoleculargenetictestingu">Table 1</a>).</p><p>Note: Distinguishing between <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita depends mainly on the family history (i.e., the presence of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent), as some pathogenic variants can occur in both autosomal recessive myotonia congenita and autosomal dominant myotonia congenita.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>CLCN1</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CLCN1</i> and other genes of interest (see <a href="#myotonia-c.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of myotonia congenita.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="myotonia-c.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Myotonia Congenita</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1355/table/myotonia-c.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonia-c.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myotonia-c.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_myotonia-c.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_myotonia-c.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_myotonia-c.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CLCN1</i></td><td headers="hd_h_myotonia-c.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_myotonia-c.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;95%</td></tr><tr><td headers="hd_h_myotonia-c.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_myotonia-c.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%-5%&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="myotonia-c.TF.1.1"><p class="no_margin">See <a href="/books/NBK1355/#myotonia-c.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#myotonia-c.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="myotonia-c.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="myotonia-c.TF.1.3"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic <i>CLCN1</i> deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>4. </dt><dd><div id="myotonia-c.TF.1.4"><p class="no_margin">A single study of 60 preselected patients revealed larger deletions/duplications in four [<a class="bk_pop" href="#myotonia-c.REF.raja_rayan.2012.1953">Raja Rayan et al 2012</a>].</p></div></dd></dl></div></div></div></div></div><div id="myotonia-c.Clinical_Characteristics"><h2 id="_myotonia-c_Clinical_Characteristics_">Clinical Characteristics</h2><div id="myotonia-c.Clinical_Description"><h3>Clinical Description</h3><p><b>The age of onset</b> is variable. In <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita, onset of symptoms is usually in infancy or early childhood. In <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita, the average age of onset is slightly older. In both conditions, onset may be as late as the third or fourth decade of life.</p><p><b>Muscle stiffness.</b> Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved.</p><ul><li class="half_rhythm"><div>The physician may note that the individual cannot extend the fingers after shaking hands, or a myotonic contraction may be elicited by percussion of muscles (e.g., the tongue, finger extensors, or thenar muscles).</div></li><li class="half_rhythm"><div>The stiffness can be relieved by repeated contractions of the muscle, a feature known as the "warm-up" phenomenon. Muscles are usually hypertrophic.</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form is often associated with more severe symptoms than seen in the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> form.</div></li></ul><p><b>Muscle weakness.</b> Individuals with the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form may have progressive, minor distal weakness and attacks of transient weakness brought on by movement after rest. Occasionally, proximal weakness or distal myopathy has been reported [<a class="bk_pop" href="#myotonia-c.REF.nagamitsu.2000.1697">Nagamitsu et al 2000</a>].</p><p><b>Extramuscular manifestations</b> such as early cataracts, abnormal cardiac conduction, or endocrine dysfunction are absent.</p></div><div id="myotonia-c.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>The phenotypic manifestations of the pathogenic variants in <i>CLCN1</i> can be variable even within the same family [<a class="bk_pop" href="#myotonia-c.REF.sun.2001.903">Sun et al 2001</a>, <a class="bk_pop" href="#myotonia-c.REF.coldingj_rgensen.2005.19">Colding-J&#x000f8;rgensen 2005</a>]. Cases of semi-dominant inheritance, in which a homozygote is more severely affected than a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>, have been reported [<a class="bk_pop" href="#myotonia-c.REF.kuo.2006.342">Kuo et al 2006</a>, <a class="bk_pop" href="#myotonia-c.REF.lin.2006.1043">Lin et al 2006</a>].</p><p>Some individuals with the pathogenic variants <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Gly230Glu</a> and <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Thr310Met</a> have been reported to experience a fluctuating <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> triggered by pregnancy [<a class="bk_pop" href="#myotonia-c.REF.lacomis.1999.133">Lacomis et al 1999</a>, <a class="bk_pop" href="#myotonia-c.REF.wu.2002.2392">Wu et al 2002</a>] and some with the <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Phe428Ser</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported as having a phenotype reminiscent of paramyotonia congenita [<a class="bk_pop" href="#myotonia-c.REF.wu.2002.2392">Wu et al 2002</a>].</p><p>Occasionally, proximal weakness (in individuals with the <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Thr550Met</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) or distal myopathy (in individuals with the <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Pro932Leu</a> pathogenic variant) has been reported [<a class="bk_pop" href="#myotonia-c.REF.nagamitsu.2000.1697">Nagamitsu et al 2000</a>]. However, the association of these features with <i>CLCN1</i> pathogenic variants has been challenged [<a class="bk_pop" href="#myotonia-c.REF.simpson.2004.185">Simpson et al 2004</a>, <a class="bk_pop" href="#myotonia-c.REF.coldingj_rgensen.2005.19">Colding-J&#x000f8;rgensen 2005</a>].</p></div><div id="myotonia-c.Penetrance"><h3>Penetrance</h3><p>The majority of the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pathogenic variants can be associated with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Family members <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may exhibit variable phenotypes ranging from absence of myotonia to severe myotonia.</p></div><div id="myotonia-c.Nomenclature"><h3>Nomenclature</h3><p>Autosomal dominant myotonia congenita is also known as Thomsen disease.</p><p>Autosomal recessive myotonia congenita is also known as Becker disease.</p><p>Myotonia levior is essentially the same as myotonia congenita.</p></div><div id="myotonia-c.Prevalence"><h3>Prevalence</h3><p>Myotonia congenita was originally estimated to occur with a frequency of 1:23,000 for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita and 1:50,000 for the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form [<a class="bk_pop" href="#myotonia-c.REF.becker.1977">Becker 1977</a>]. Subsequent studies have suggested that the autosomal recessive form is more common than the autosomal dominant form. In a large cohort of more than 300 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from the UK, autosomal dominant pathogenic variants were found in only 37% of individuals in whom a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified [<a class="bk_pop" href="#myotonia-c.REF.fialho.2007.3265">Fialho et al 2007</a>].</p><p>In northern Scandinavia, the prevalence of myotonia congenita has been estimated at 1:10,000 [<a class="bk_pop" href="#myotonia-c.REF.papponen.1999.297">Papponen et al 1999</a>, <a class="bk_pop" href="#myotonia-c.REF.sun.2001.903">Sun et al 2001</a>], whereas the worldwide prevalence has been estimated at 1:100,000 [<a class="bk_pop" href="#myotonia-c.REF.emery.1991.19">Emery 1991</a>].</p></div></div><div id="myotonia-c.Genetically_Related_Allelic_D"><h2 id="_myotonia-c_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>A single <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Phe428Ser</a>, has been associated with a paramyotonia-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in one individual [<a class="bk_pop" href="#myotonia-c.REF.weiss.1997.195">Weiss &#x00026; Mayer 1997</a>, <a class="bk_pop" href="#myotonia-c.REF.wu.2002.2392">Wu et al 2002</a>]. This finding is unique and should be interpreted with caution [<a class="bk_pop" href="#myotonia-c.REF.coldingj_rgensen.2005.19">Colding-J&#x000f8;rgensen 2005</a>]. Paramyotonia congenita usually results from mutation of <i>SCN4A</i>.</p><p>Another variant, p.Arg976Ter, has been associated with epilepsy in a single individual. The variant was shown to be a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> event in the patient, which apart from generalized pharmacoresistant epilepsy also demonstrated mild myotonic features on specific assessment. Further evidence is needed to substantiate the possible relationship between <i>CLCN1</i> variants and epilepsy [<a class="bk_pop" href="#myotonia-c.REF.chen.2013.1078">Chen et al 2013</a>].</p><p>Pathogenic variants in <i>CLCN1</i> have been identified in patients with confirmed <a href="/books/n/gene/myotonic-d2/">myotonic dystrophy type 2</a> (DM2) or sodium channel myotonia. This coexistence may modulate the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and, for DM2, exaggerate the clinical symptoms [<a class="bk_pop" href="#myotonia-c.REF.cardani.2012.2090">Cardani et al 2012</a>, <a class="bk_pop" href="#myotonia-c.REF.furby.2014.953">Furby et al 2014</a>].</p></div><div id="myotonia-c.Differential_Diagnosis"><h2 id="_myotonia-c_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of myotonia congenita includes other disorders in which myotonia is a prominent finding. Myotonia congenita can usually be distinguished from these disorders based on the following:</p><ul><li class="half_rhythm"><div>Factors that provoke or alleviate myotonia</div></li><li class="half_rhythm"><div>Presence or absence of extramuscular manifestations</div></li><li class="half_rhythm"><div>Findings on electrodiagnostic testing</div></li></ul><p><b>Diseases to consider in the differential diagnosis</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Paramyotonia congenita</b> (OMIM <a href="http://omim.org/entry/168300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">168300</a>) (caused by <i>SCN4A</i> pathogenic variants) may sometimes be difficult to distinguish from myotonia congenita:</div><ul><li class="half_rhythm"><div>Both conditions present with episodes of generalized stiffness in early childhood. Individuals with paramyotonia congenita display extreme cold sensitivity with cold-induced severe stiffness usually followed by true weakness, features not seen in myotonia congenita; however, individuals with myotonia congenita may report some aggravation of stiffness in the cold.</div></li><li class="half_rhythm"><div>Individuals with myotonia congenita display a pronounced warm-up phenomenon, in which myotonia is relieved with repeated muscle contractions. Conversely, in paramyotonia congenita, repeated muscle contractions may aggravate stiffness (also termed paradoxical myotonia).</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Potassium-aggravated myotonia</b> (OMIM <a href="http://omim.org/entry/608390" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608390</a>) (caused by <i>SCN4A</i> pathogenic variants) is a diverse group of rare sodium channel disorders. Up to 20% of persons suspected of having myotonia congenita may in fact have pathogenic variants in <i>SCN4A</i> [<a class="bk_pop" href="#myotonia-c.REF.trip.2008.921">Trip et al 2008</a>]. In some cases, the myotonia may be associated with episodes of hyperkalemic periodic paralysis (see <a href="/books/n/gene/hyper-pp/">Hyperkalemic Periodic Paralysis Type 1</a>). However, if episodes of periodic paralysis are absent, sodium channel (potassium-aggravated) myotonia may be difficult to distinguish from chloride channel myotonia (myotonia congenita) on clinical grounds alone.</div><div class="half_rhythm">The following clues are helpful [<a class="bk_pop" href="#myotonia-c.REF.shapiro.2002">Shapiro &#x00026; Ruff 2002</a>, <a class="bk_pop" href="#myotonia-c.REF.tan.2011">Tan et al 2011</a>]:</div><ul><li class="half_rhythm"><div>Characteristically, symptoms of sodium channel disorders worsen with potassium ingestion, an aggravation that is not seen in myotonia congenita.</div></li><li class="half_rhythm"><div>Some individuals with sodium channel myotonia have exercise-induced, delayed-onset myotonia, in which muscle contractions induce myotonia after a period of delay. This phenomenon contrasts with the warm-up phenomenon seen in myotonia congenita.</div></li><li class="half_rhythm"><div>Eye closure myotonia is more frequent in sodium channel myotonia, whereas falls are more frequent in chloride channel myotonia [<a class="bk_pop" href="#myotonia-c.REF.tan.2011">Tan et al 2011</a>].</div></li><li class="half_rhythm"><div>Many individuals with sodium channel myotonia have painful myotonia, whereas pain is uncommon in chloride channel myotonia.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><a href="/books/n/gene/myotonic-d/"><b>Myotonic dystrophy type 1</b></a>
<b>(DM1)</b> and <a href="/books/n/gene/myotonic-d2/"><b>myotonic dystrophy type 2</b></a>
<b>(DM2)</b> should always be considered in the differential diagnosis of myotonia congenita, as the extramuscular manifestations of DM1 and DM2 have important implications for prognosis and management. Although some degree of muscular weakness and wasting may be observed in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita, the pattern of muscle weakness is very different and extramuscular manifestations including early cataracts, abnormal cardiac conduction, or endocrine dysfunction found in DM1 and DM2 are not observed in myotonia congenita. However, the lack of these extramuscular features does not rule out, for example, a mild form of myotonic dystrophy type I.</div><div class="half_rhythm">DM1 is caused by expansion of a CTG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> in <i>DMPK1</i>; DM2 is caused by a CCTG repeat expansion in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 1 of <i>CNBP</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding cellular nucleic acid binding protein (zinc finger protein 9) [<a class="bk_pop" href="#myotonia-c.REF.liquori.2001.864">Liquori et al 2001</a>]. Inheritance of DM1 and DM2 is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li></ul></div><div id="myotonia-c.Management"><h2 id="_myotonia-c_Management_">Management</h2><div id="myotonia-c.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with myotonia congenita, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li><li class="half_rhythm"><div>Consultation with a neurologist or other relevant specialist to evaluate the need for pharmacologic treatment</div></li></ul></div><div id="myotonia-c.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Some individuals with minor complaints may only need to accommodate their activities and lifestyles to reduce symptoms [<a class="bk_pop" href="#myotonia-c.REF.shapiro.2002">Shapiro &#x00026; Ruff 2002</a>]. Myotonic stiffness may respond to sodium channel blockers or other pharmacologic treatment options:</p><ul><li class="half_rhythm"><div><b>Mexiletine</b>, a lidocaine derivative, is the best documented treatment option. In a double-blind randomized trial, mexiletine (200 mg 3x/day) significantly reduced stiffness in a group of 59 patients with myotonia, 34 of whom had myotonia congenita [<a class="bk_pop" href="#myotonia-c.REF.statland.2012.1357">Statland et al 2012</a>]. In clinical practice, doses generally begin at 150 mg twice a day, increasing slowly as needed up to 200-300 mg three times a day. The most common potential side effects, including epigastric discomfort, nausea, lightheadedness, dizziness, tremor, and ataxia, are reversible with dose reduction.</div></li><li class="half_rhythm"><div>Other sodium channel blockers such as <b>phenytoin</b> and <b>carbamazepine</b> have been reported to have beneficial effects [<a class="bk_pop" href="#myotonia-c.REF.conravey.2010.16">Conravey &#x00026; Santana-Gould 2010</a>].</div></li><li class="half_rhythm"><div>Compounds with other presumed modes of action such as <b>quinine</b>, <b>dantrolene</b>, or <b>acetazolamide</b> may be beneficial in some cases [<a class="bk_pop" href="#myotonia-c.REF.shapiro.2002">Shapiro &#x00026; Ruff 2002</a>].</div></li></ul><p>See review in <a class="bk_pop" href="#myotonia-c.REF.conravey.2010.16">Conravey &#x00026; Santana-Gould [2010]</a> for a detailed description of these treatment options.</p></div><div id="myotonia-c.Prevention_of_Primary_Manifes"><h3>Prevention of Primary Manifestations</h3><p>Exercise temporarily alleviates myotonia (the warm-up effect). A long-term beneficial effect of gymnastics is sometimes reported by <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; the effect has not been systematically studied.</p></div><div id="myotonia-c.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>In general, anesthesia should be used with caution [<a class="bk_pop" href="#myotonia-c.REF.bandschapp.2013.824">Bandschapp &#x00026; Laizzo 2013</a>]. Particular care must be taken with the use of <b>depolarizing muscle relaxants</b> during anesthesia because they may cause adverse anesthesia-related events. Because life-threatening muscle spasms and secondary ventilation difficulties occurred following a preoperative injection of <b>suxamethonium</b>, <a class="bk_pop" href="#myotonia-c.REF.farbu.2003.630">Farbu et al [2003]</a> recommended that suxamethonium be avoided in individuals with myotonia congenita.</p><p>Note: Non-depolarizing muscle relaxants appear to act normally in individuals with myotonia congenita but do not counteract a myotonic response caused by suxamethonium [<a class="bk_pop" href="#myotonia-c.REF.farbu.2003.630">Farbu et al 2003</a>].</p><p>In rare cases, injections of <b>adrenaline</b> or <b>selective beta-adrenergic agonists</b> in high doses may aggravate myotonia.</p><p>The beta-antagonist <b>propranolol</b> has likewise been reported to worsen myotonia [<a class="bk_pop" href="#myotonia-c.REF.blessing.1977.73">Blessing &#x00026; Walsh 1977</a>]. Accordingly, beta-agonists and beta-antagonists should be used with caution and particular care should be taken with the use of intravenous <b>fenoterol</b> or <b>ritodrine</b>.</p><p><b>Colchicine</b> may cause a myopathy with myotonia in individuals with renal insufficiency [<a class="bk_pop" href="#myotonia-c.REF.rutkove.1996.870">Rutkove et al 1996</a>] and may thus also, in theory, aggravate the myotonia of individuals with myotonia congenita.</p></div><div id="myotonia-c.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>Because individuals with myotonia congenita may be at increased risk for adverse anesthesia-related events, testing of at-risk individuals during childhood to clarify their genetic status is appropriate.</p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk relatives.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are not known, electromyography can be used to clarify the disease status of at-risk relatives.</div></li></ul><p>See <a href="#myotonia-c.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="myotonia-c.Pregnancy_Management"><h3>Pregnancy Management</h3><p>For an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother, a comprehensive birth plan is recommended [<a class="bk_pop" href="#myotonia-c.REF.gorthi.2013.293">Gorthi et al 2013</a>] to minimize the risks of muscular spasms due to factors such as medications, intramuscular injections, and cold.</p></div><div id="myotonia-c.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>A trial with <b>lamotrigine</b> is ongoing (NCT01939561).</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="myotonia-c.Genetic_Counseling"><h2 id="_myotonia-c_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="myotonia-c.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Myotonia congenita can be inherited in either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (Becker disease) or an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (Thomsen disease). A clear distinction can be difficult because the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may occur in families with autosomal recessive inheritance and families with autosomal dominant inheritance.</p></div><div id="myotonia-c.Risk_to_Family_Members__Autos"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The majority of individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita may potentially have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is unknown but presumably very low.</div></li><li class="half_rhythm"><div>If the <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparently <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include electromyography. Alternatively, a methodology developed to detect low-level <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a>, such as an <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">NGS</a>-based deep sequencing approach, can potentially uncover a low mosaic state in one of the parents.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita may appear to be negative because of failure to recognize the disorder in family members, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, or early death of the parent before the onset of symptoms. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and electromyography) have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, the sibs of a proband with clinically unaffected parents are still at increased risk for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita has a 50% chance of inheriting the <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents. If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="myotonia-c.Risk_to_Family_Members__Autos_1"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita are obligate heterozygotes (i.e., carriers of one <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. Occasionally, the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita (the proband has two <i>CLCN1</i> pathogenic variants) can show subtle evidence of myotonia on EMG testing. However, they are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are mostly asymptomatic. Occasionally, on thorough clinical evaluation, heterozygotes can show subtle evidence of myotonia on EMG testing. However, they are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita are obligate heterozygotes (carriers of a <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="myotonia-c.Carrier_Heterozygote_Detectio"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>CLCN1</i> pathogenic variants in the family.</p></div><div id="myotonia-c.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#myotonia-c.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives.</p><p><b>Establishing the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case</b> (i.e., the occurrence of a single individual with myotonia congenita in a family) may not be possible unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> reveals two <i>CLCN1</i> pathogenic variants <i>in trans</i>, demonstrating <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance. Confirmation of phase by <a class="def" href="/books/n/gene/glossary/def-item/segregation/">segregation</a> analysis is important, as a single <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> with two pathogenic variants has been described [<a class="bk_pop" href="#myotonia-c.REF.brugnoni.2013.581">Brugnoni et al 2013</a>]. It should be noted that cases of semi-dominant inheritance, in which a homozygote is more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> than a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>, have been reported [<a class="bk_pop" href="#myotonia-c.REF.kuo.2006.342">Kuo et al 2006</a>, <a class="bk_pop" href="#myotonia-c.REF.lin.2006.1043">Lin et al 2006</a>].</p><p><b>Testing of at-risk asymptomatic relatives</b> of individuals with myotonia congenita is possible after <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has identified the specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family. Such testing should be performed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing. Because individuals with myotonia congenita may be at risk for adverse anesthesia-related events, testing of at-risk individuals during childhood is appropriate.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="myotonia-c.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for myotonia congenita are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="myotonia-c.Resources"><h2 id="_myotonia-c_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 00-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Myotonia-Congenita-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myotonia Congenita Information Page</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=myotoniacongenita" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myotonia congenita</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li></ul></div><div id="myotonia-c.Molecular_Genetics"><h2 id="_myotonia-c_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="myotonia-c.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Myotonia Congenita: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1355/table/myotonia-c.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonia-c.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_myotonia-c.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_myotonia-c.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_myotonia-c.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_myotonia-c.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_myotonia-c.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_myotonia-c.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_myotonia-c.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1180" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CLCN1</i></a></td><td headers="hd_b_myotonia-c.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1180" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q34</a></td><td headers="hd_b_myotonia-c.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P35523" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Chloride channel protein 1</a></td><td headers="hd_b_myotonia-c.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/CLCN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Chloride channel 1, skeletal muscle (CLCN1) @ LOVD</a></td><td headers="hd_b_myotonia-c.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CLCN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CLCN1</a></td><td headers="hd_b_myotonia-c.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CLCN1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CLCN1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="myotonia-c.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="myotonia-c.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Myotonia Congenita (<a href="/omim/118425,160800,255700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1355/table/myotonia-c.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonia-c.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/118425" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">118425</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHLORIDE CHANNEL 1, SKELETAL MUSCLE; CLCN1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/160800" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">160800</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYOTONIA CONGENITA, AUTOSOMAL DOMINANT</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/255700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">255700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE</td></tr></tbody></table></div></div><div id="myotonia-c.Molecular_Genetic_Pathogenesi"><h3>Molecular Genetic Pathogenesis</h3><p><i>CLCN1</i> encodes the voltage-gated chloride channel ClC-1 (chloride channel protein 1), which is primarily expressed in the sarcolemma, where its main function is to regulate excitability and to stabilize the resting potential. The channel functions as a homodimer, and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita is believed to result from two mutated alleles that reduce functionality, whereas <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita is believed to result from a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> "poisoning" the channel. The latter variants are therefore mainly located in the dimer interface, whereas variants associated with recessive MC can be located throughout the protein [<a class="bk_pop" href="#myotonia-c.REF.sk_lov_.2013.e82549">Sk&#x000e1;lov&#x000e1; et al 2013</a>].</p><p>Normally, the chloride conductance contributes 85% to the resting membrane conductance of human muscle, ensuring its electrical stability. The chloride conductance is crucial for countering the depolarizing effect of potassium (K<sup>+</sup>) accumulation in T tubules. If the chloride conductance is reduced to 40% or less, K<sup>+</sup> accumulation in the T-tubular lumen depolarizes the surface membrane sufficiently to initiate self-sustaining action potentials causing a prolonged (myotonic) contraction [<a class="bk_pop" href="#myotonia-c.REF.barchi.2001">Barchi 2001</a>]. A reduction of chloride conductance to 50% apparently does not cause myotonia, because <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> carriers of nonfunctional ("<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>") pathogenic variants are usually asymptomatic.</p><p>On a research basis, the functional consequences of a number of <i>CLCN1</i> pathogenic variants have been investigated by expression of the corresponding mutated <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> sequences in <i>Xenopus</i> oocytes or mammalian cells followed by whole-cell patch-clamp recordings.</p><p>The myotonic phenotypes of <a href="/books/n/gene/myotonic-d/">myotonic dystrophy type 1</a> and <a href="/books/n/gene/myotonic-d2/">type 2</a> are believed to result from missplicing of <i>CLCN1</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> due to an RNA toxic effect of the pathogenic expansion of a CTG repeat in <i>DMPK</i> (DM1) and a CCTG repeat in <i>CNBP</i> (DM2) [<a class="bk_pop" href="#myotonia-c.REF.charletb.2002.45">Charlet-B et al 2002</a>, <a class="bk_pop" href="#myotonia-c.REF.mankodi.2002.35">Mankodi et al 2002</a>]. A similar effect has recently been proposed for <a href="/books/n/gene/huntington/">Huntington disease</a> (HD), where a CAG expansion in <i>HTT</i> in a mouse model impairs <i>CLCN1</i> function which in turn could contribute to the chorea, dystonia, and stiffness seen in HD [<a class="bk_pop" href="#myotonia-c.REF.waters.2013.9160">Waters et al 2013</a>].</p><p>The majority of the more than 275 different <i>CLCN1</i> pathogenic variants identified to date are associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita. Approximately 20 pathogenic variants have solely been associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> myotonia congenita, whereas approximately 12 pathogenic variants associate with both autosomal recessive and autosomal dominant myotonia congenita, making it difficult to predict <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>.</p><p>Unambiguous <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pedigrees have been described only for <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Gly230Glu</a>, <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Thr310Met</a>, <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Ala531Val</a>, and <a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">p.Arg894Ter</a>. This peculiar phenomenon may be explained by the following [<a class="bk_pop" href="#myotonia-c.REF.koty.1996.963">Koty et al 1996</a>, <a class="bk_pop" href="#myotonia-c.REF.mail_nder.1996.317">Mail&#x000e4;nder et al 1996</a>, <a class="bk_pop" href="#myotonia-c.REF.zhang.1996.993">Zhang et al 1996</a>, <a class="bk_pop" href="#myotonia-c.REF.plassartschiess.1998.1176">Plassart-Schiess et al 1998</a>, <a class="bk_pop" href="#myotonia-c.REF.dun_.2004.738">Dun&#x000f8; et al 2004</a>, <a class="bk_pop" href="#myotonia-c.REF.bernard.2008.163">Bernard et al 2008</a>, <a class="bk_pop" href="#myotonia-c.REF.richardson.2014.593">Richardson et al 2014</a>]:</p><ul><li class="half_rhythm"><div>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> pathogenic variants</div></li><li class="half_rhythm"><div>Incomplete dominance</div></li><li class="half_rhythm"><div>Haplotype background</div></li><li class="half_rhythm"><div>Incomplete <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> detection</div></li><li class="half_rhythm"><div>Differences in allelic expression</div></li></ul><p><b>Gene structure.</b>
<i>CLCN1</i> spans 36 kb and contains 23 exons with a transcript length of 3093 nucleotides. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1355/#myotonia-c.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 275 different pathogenic variants have been identified, the majority of which are associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> myotonia congenita. Pathogenic variants (both recessive and dominant) appear to be scattered throughout the coding sequence and are mostly <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants (<a class="figpopup" href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object" rid-figpopup="figmyotoniacTclcn1variantsdiscussedin" rid-ob="figobmyotoniacTclcn1variantsdiscussedin">Table 2</a>). Pathogenic variants causing dominant myotonia congenita are often located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8 [<a class="bk_pop" href="#myotonia-c.REF.fialho.2007.3265">Fialho et al 2007</a>].</p><p>The p.Arg894Ter <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is probably the most common semi-dominant pathogenic variant with homozygotes being more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> than heterozygotes [<a class="bk_pop" href="#myotonia-c.REF.kuo.2006.342">Kuo et al 2006</a>, <a class="bk_pop" href="#myotonia-c.REF.lin.2006.1043">Lin et al 2006</a>].</p><div id="myotonia-c.T.clcn1_variants_discussed_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>CLCN1</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1355/table/myotonia-c.T.clcn1_variants_discussed_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonia-c.T.clcn1_variants_discussed_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.689G&#x0003e;A</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly230Glu</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_3" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=119433676" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000083<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=119433677" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000074<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.929C&#x0003e;T</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">pThr310Met</td></tr><tr><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1283T&#x0003e;C</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe428Ser</td></tr><tr><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1592C&#x0003e;T</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala531Val</td></tr><tr><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1649C&#x0003e;T</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr550Met</td></tr><tr><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2680C&#x0003e;T</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg894Ter</td></tr><tr><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2795C&#x0003e;T</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro932Leu</td></tr><tr><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2926C&#x0003e;T</td><td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg976Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CLCN1</i> encodes the protein ClC-1, which consists of 988 amino acids and contains numerous transmembrane domains. The functional ClC-1 channel contributes approximately 80% of the total resting conductance and determines membrane excitability.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Recessive pathogenic variants are presumed to cause loss of function of the channel; dominant pathogenic variants presumably act through a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> mechanism, by primarily affecting dimerization [<a class="bk_pop" href="#myotonia-c.REF.sk_lov_.2013.e82549">Sk&#x000e1;lov&#x000e1; et al 2013</a>].</p></div></div><div id="myotonia-c.References"><h2 id="_myotonia-c_References_">References</h2><div id="myotonia-c.Published_Guidelines__Consens"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.tan.2011">Tan SV, Matthews E, Barber M, Burge JA, Rajakulendran S, Fialho D, Sud R, Haworth A, Koltzenburg M, Hanna MG. Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies. Available <a href="http://onlinelibrary.wiley.com/doi/10.1002/ana.22238/pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2011. Accessed 12-19-18. [<a href="/pmc/articles/PMC3051421/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3051421</span></a>] [<a href="/pubmed/21387378" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21387378</span></a>]</div></li></ul></div><div id="myotonia-c.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.bandschapp.2013.824">Bandschapp O, Laizzo PA. Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses. <span><span class="ref-journal">Paediatr Anaesth. </span>2013;<span class="ref-vol">23</span>:824–33.</span> [<a href="/pubmed/23802937" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23802937</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.barchi.2001">Barchi R. The pathophysiology of excitation in skeletal muscle. In: Karpati G, Hilton-Jones D, Griggs RC, eds. <em>Disorders of Voluntary Muscle</em>. 7 ed. Cambridge, UK: Cambridge University Press. 2001:168-86.</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.becker.1977">Becker PE. <em>Myotonia Congenita and Syndromes Associated with Myotonia. Topics in Human Genetics</em>. Stuttgart, Germany: Georg Thieme. 1977.</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.bernard.2008.163">Bernard G, Poulin C, Puymirat J, Sternberg D, Shevell M. Dosage effect of a dominant CLCN1 mutation: a novel syndrome. <span><span class="ref-journal">J Child Neurol. </span>2008;<span class="ref-vol">23</span>:163–6.</span> [<a href="/pubmed/18263754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18263754</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.blessing.1977.73">Blessing W, Walsh JC. Myotonia precipitated by propranolol therapy. <span><span class="ref-journal">Lancet. </span>1977;<span class="ref-vol">1</span>:73–4.</span> [<a href="/pubmed/63714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 63714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.brugnoni.2013.581">Brugnoni R, Kapetis D, Imbrici P, Pessia M, Canioni E, Colleoni L, de Rosbo NK, Morandi L, Cudia P, Gashemi N, Bernasconi P, Desaphy JF, Conte D, Mantegazza R. A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene. <span><span class="ref-journal">J Hum Genet. </span>2013;<span class="ref-vol">58</span>:581–7.</span> [<a href="/pubmed/23739125" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23739125</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.cardani.2012.2090">Cardani R, Giagnacovo M, Botta A, Rinaldi F, Morgante A, Udd B, Raheem O, Penttil&#x000e4; S, Suominen T, Renna LV, Sansone V, Bugiardini E, Novelli G, Meola G. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2. <span><span class="ref-journal">J Neurol. </span>2012;<span class="ref-vol">259</span>:2090–9.</span> [<a href="/pubmed/22407275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22407275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.charletb.2002.45">Charlet-B N, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. <span><span class="ref-journal">Mol Cell. </span>2002;<span class="ref-vol">10</span>:45–53.</span> [<a href="/pubmed/12150906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12150906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.chen.2013.1078">Chen TT, Klassen TL, Goldman AM, Marini C, Guerrini R, Noebels JL. Novel brain expression of ClC-1 chloride channels and enrichment of CLCN1 variants in epilepsy. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:1078–85.</span> [<a href="/pmc/articles/PMC3662306/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3662306</span></a>] [<a href="/pubmed/23408874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23408874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.coldingj_rgensen.2005.19">Colding-J&#x000f8;rgensen E. Phenotypic variability in myotonia congenita. <span><span class="ref-journal">Muscle Nerve. </span>2005;<span class="ref-vol">32</span>:19–34.</span> [<a href="/pubmed/15786415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15786415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.conravey.2010.16">Conravey A, Santana-Gould L. Myotonia congenita and myotonic dystrophy: surveillance and management. <span><span class="ref-journal">Curr Treat Options Neurol. </span>2010;<span class="ref-vol">12</span>:16–28.</span> [<a href="/pubmed/20842486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20842486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.dun_.2004.738">Dun&#x000f8; M, Colding-J&#x000f8;rgensen E, Grunnet M, Jespersen T, Vissing J, Schwartz M. Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype. <span><span class="ref-journal">Eur J Hum Genet. </span>2004;<span class="ref-vol">12</span>:738–43.</span> [<a href="/pubmed/15162127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15162127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.emery.1991.19">Emery AE. Population frequencies of inherited neuromuscular diseases - a world survey. <span><span class="ref-journal">Neuromuscul Disord. </span>1991;<span class="ref-vol">1</span>:19–29.</span> [<a href="/pubmed/1822774" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1822774</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.farbu.2003.630">Farbu E, Softeland E, Bindoff LA. Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders. <span><span class="ref-journal">Acta Anaesthesiol Scand. </span>2003;<span class="ref-vol">47</span>:630–4.</span> [<a href="/pubmed/12699527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12699527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.fialho.2007.3265">Fialho D, Schorge S, Pucovska U, Davies NP, Labrum R, Haworth A, Stanley E, Sud R, Wakeling W, Davis MB, Kullmann DM, Hanna MG. Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:3265–74.</span> [<a href="/pubmed/17932099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17932099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.furby.2014.953">Furby A, Vicart S, Camdessanch&#x000e9; JP, Fournier E, Chabrier S, Lagrue E, Paricio C, Blondy P, Touraine R, Sternberg D, Fontaine B. Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia. <span><span class="ref-journal">Neuromuscul Disord. </span>2014;<span class="ref-vol">24</span>:953–9.</span> [<a href="/pubmed/25088311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25088311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.gorthi.2013.293">Gorthi S, Radbourne S, Drury N, Rajagopalan C. Management of pregnancy with Thomsen's disease. <span><span class="ref-journal">Eur J Obstet Gynecol Reprod Biol. </span>2013;<span class="ref-vol">170</span>:293–4.</span> [<a href="/pubmed/23806446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23806446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.koty.1996.963">Koty PP, Pegoraro E, Hobson G, Marks HG, Turel A, Flagler D, Cadaldini M, Angelini C, Hoffman EP. Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect. <span><span class="ref-journal">Neurology. </span>1996;<span class="ref-vol">47</span>:963–8.</span> [<a href="/pubmed/8857727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8857727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.kuo.2006.342">Kuo HC, Hsiao KM, Chang LI, You TH, Yeh TH, Huang CC. Novel mutations at carboxyl terminus of CIC-1 channel in myotonia congenita. <span><span class="ref-journal">Acta Neurol Scand. </span>2006;<span class="ref-vol">113</span>:342–6.</span> [<a href="/pubmed/16629771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16629771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.lacomis.1999.133">Lacomis D, Gonzales JT, Giuliani MJ. Fluctuating clinical myotonia and weakness from Thomsen's disease occurring only during pregnancies. <span><span class="ref-journal">Clin Neurol Neurosurg. </span>1999;<span class="ref-vol">101</span>:133–6.</span> [<a href="/pubmed/10467912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10467912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.lin.2006.1043">Lin MJ, You TH, Pan H, Hsiao KM. Functional characterization of CLCN1 mutations in Taiwanese patients with myotonia congenita via heterologous expression. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2006;<span class="ref-vol">351</span>:1043–7.</span> [<a href="/pubmed/17097617" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17097617</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.liquori.2001.864">Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. <span><span class="ref-journal">Science. </span>2001;<span class="ref-vol">293</span>:864–7.</span> [<a href="/pubmed/11486088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11486088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.mail_nder.1996.317">Mail&#x000e4;nder V, Heine R, Deymeer F, Lehmann-Horn F. Novel muscle chloride channel mutations and their effects on heterozygous carriers. <span><span class="ref-journal">Am J Hum Genet. </span>1996;<span class="ref-vol">58</span>:317–24.</span> [<a href="/pmc/articles/PMC1914535/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1914535</span></a>] [<a href="/pubmed/8571958" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8571958</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.mankodi.2002.35">Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. <span><span class="ref-journal">Mol Cell. </span>2002;<span class="ref-vol">10</span>:35–44.</span> [<a href="/pubmed/12150905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12150905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.nagamitsu.2000.1697">Nagamitsu S, Matsuura T, Khajavi M, Armstrong R, Gooch C, Harati Y, Ashizawa T. A "dystrophic" variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">55</span>:1697–703.</span> [<a href="/pubmed/11113225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11113225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.papponen.1999.297">Papponen H, Toppinen T, Baumann P, Myllyla V, Leisti J, Kuivaniemi H, Tromp G, Myllyla R. Founder mutations and the high prevalence of myotonia congenita in northern Finland. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">53</span>:297–302.</span> [<a href="/pubmed/10430417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10430417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.plassartschiess.1998.1176">Plassart-Schiess E, Gervais A, Eymard B, Lagueny A, Pouget J, Warter JM, Fardeau M, Jentsch TJ, Fontaine B. Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance. <span><span class="ref-journal">Neurology. </span>1998;<span class="ref-vol">50</span>:1176–9.</span> [<a href="/pubmed/9566422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9566422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.raja_rayan.2012.1953">Raja Rayan DL, Haworth A, Sud R, Matthews E, Fialho D, Burge J, Portaro S, Schorge S, Tuin K, Lunt P, McEntagart M, Toscano A, Davis MB, Hanna MG. A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:1953–8.</span> [<a href="/pmc/articles/PMC3369509/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3369509</span></a>] [<a href="/pubmed/22649220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22649220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.richardson.2014.593">Richardson RC, Tarleton JC, Bird TD, Gospe SM Jr. Truncating CLCN1 mutations in myotonia congenita: variable patterns of inheritance. <span><span class="ref-journal">Muscle Nerve. </span>2014;<span class="ref-vol">49</span>:593–600.</span> [<a href="/pubmed/23893571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23893571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.rutkove.1996.870">Rutkove SB, DeGirolami U, Preston DC, Freeman R, Nardin RA, Gouras GK, Johns DR, Raynor EM. Myotonia in colchicine myoneuropathy. <span><span class="ref-journal">Muscle Nerve. </span>1996;<span class="ref-vol">19</span>:870–5.</span> [<a href="/pubmed/8965841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8965841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.shapiro.2002">Shapiro B, Ruff R. Disorders of skeletal muscle membrane excitability: myotonia congenita, paramyotonia congenita, periodic paralysis, and related disorders. In: Katirji B, Kaminski H, Preston D, Ruff R, Shapiro B, eds. <em>Neuromuscular Disorders in Clinical Practice</em>. Philadelphia, PA: Butterworth-Heinemann; 2002:987-1020.</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.simpson.2004.185">Simpson BJ, Height TA, Rychkov GY, Nowak KJ, Laing NG, Hughes BP, Bretag AH. Characterization of three myotonia-associated mutations of the CLCN1 chloride channel gene via heterologous expression. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">24</span>:185.</span> [<a href="/pubmed/15241802" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15241802</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.sk_lov_.2013.e82549">Sk&#x000e1;lov&#x000e1; D, Z&#x000ed;dkov&#x000e1; J, Voh&#x000e1;&#x00148;ka S, Mazanec R, Mu&#x00161;ov&#x000e1; Z, Vondr&#x000e1;&#x0010d;ek P, Mr&#x000e1;zov&#x000e1; L, Kraus J, R&#x000e9;blov&#x000e1; K, Fajkusov&#x000e1; L. CLCN1 mutations in Czech patients with myotonia congenita, in silico analysis of novel and known mutations in the human dimeric skeletal muscle chloride channel. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e82549.</span> [<a href="/pmc/articles/PMC3859631/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3859631</span></a>] [<a href="/pubmed/24349310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24349310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.statland.2012.1357">Statland JM, Bundy BN, Wang Y, Rayan DR, Trivedi JR, Sansone VA, Salajegheh MK, Venance SL, Ciafaloni E, Matthews E, Meola G, Herbelin L, Griggs RC, Barohn RJ, Hanna MG. Consortium for Clinical Investigation of Neurologic Channelopathies. Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. <span><span class="ref-journal">JAMA. </span>2012;<span class="ref-vol">308</span>:1357–65.</span> [<a href="/pmc/articles/PMC3564227/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3564227</span></a>] [<a href="/pubmed/23032552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23032552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.sun.2001.903">Sun C, Tranebjaerg L, Torbergsen T, Holmgren G, Van Ghelue M. Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. <span><span class="ref-journal">Eur J Hum Genet. </span>2001;<span class="ref-vol">9</span>:903–9.</span> [<a href="/pubmed/11840191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11840191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.tan.2011.328">Tan SV, Matthews E, Barber M, Burge JA, Rajakulendran S, Fialho D, Sud R, Haworth A, Koltzenburg M, Hanna MG. Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies. <span><span class="ref-journal">Ann Neurol. </span>2011;<span class="ref-vol">69</span>:328–40.</span> [<a href="/pmc/articles/PMC3051421/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3051421</span></a>] [<a href="/pubmed/21387378" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21387378</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.trip.2008.921">Trip J, Drost G, Verbove DJ, van der Kooi AJ, Kuks JB, Notermans NC, Verschuuren JJ, de Visser M, van Engelen BG, Faber CG, Ginjaar IB. In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:921–9.</span> [<a href="/pubmed/18337730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18337730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.waters.2013.9160">Waters CW, Varuzhanyan G, Talmadge RJ, Voss AA. Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunction. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2013;2013;<span class="ref-vol">110</span>:9160–5.</span> [<a href="/pmc/articles/PMC3670332/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3670332</span></a>] [<a href="/pubmed/23671115" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23671115</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.weiss.1997.195">Weiss MD, Mayer RF. Temperature-sensitive repetitive discharges in paramyotonia congenita. <span><span class="ref-journal">Muscle Nerve. </span>1997;<span class="ref-vol">20</span>:195–7.</span> [<a href="/pubmed/9040658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9040658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.wu.2002.2392">Wu FF, Ryan A, Devaney J, Warnstedt M, Korade-Mirnics Z, Poser B, Escriva MJ, Pegoraro E, Yee AS, Felice KJ, Giuliani MJ, Mayer RF, Mongini T, Palmucci L, Marino M, Rudel R, Hoffman EP, Fahlke C. Novel CLCN1 mutations with unique clinical and electrophysiological consequences. <span><span class="ref-journal">Brain. </span>2002;<span class="ref-vol">125</span>:2392–407.</span> [<a href="/pubmed/12390967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12390967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonia-c.REF.zhang.1996.993">Zhang J, George AL Jr, Griggs RC, Fouad GT, Roberts J, Kwieci&#x00144;ski H, Connolly AM, Pt&#x000e1;cek LJ. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. <span><span class="ref-journal">Neurology. </span>1996;<span class="ref-vol">47</span>:993–8.</span> [<a href="/pubmed/8857733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8857733</span></a>]</div></li></ul></div></div><div id="myotonia-c.Chapter_Notes"><h2 id="_myotonia-c_Chapter_Notes_">Chapter Notes</h2><div id="myotonia-c.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>6 August 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 April 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 July 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 August 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>14 December 2004 (md) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1355</span><span class="label">PMID: <a href="/pubmed/20301529" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301529</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mstn/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/myotonic-d/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1355&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1355/?report=reader">PubReader</a></li><li><a href="/books/NBK1355/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1355" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1355" style="display:none" title="Cite this Page"><div class="bk_tt">Dunø M, Colding-Jørgensen E. Myotonia Congenita. 2005 Aug 3 [Updated 2015 Aug 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1355/pdf/Bookshelf_NBK1355.pdf">PDF version of this page</a> (435K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#myotonia-c.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#myotonia-c.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#myotonia-c.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#myotonia-c.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#myotonia-c.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#myotonia-c.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#myotonia-c.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#myotonia-c.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#myotonia-c.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#myotonia-c.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#myotonia-c.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1180[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CLCN1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1355+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1480088" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1480088" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1480088" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1480088" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301347" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Myasthenic Syndromes</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Myasthenic Syndromes<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Abicht A, Müller J S, Lochmüller H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301669" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hyperkalemic Periodic Paralysis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hyperkalemic Periodic Paralysis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Weber F, Jurkat-Rott K, Lehmann-Horn F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301559" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Caveolinopathies</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Caveolinopathies<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bruno C, Sotgia F, Gazzerro E, Minetti C, Lisanti MP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24741716" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RRM2B</i>-Related Mitochondrial Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RRM2B</i>-Related Mitochondrial Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gorman GS, Taylor RW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301529" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301529" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040e51dd21425a2569befc">Myotonia Congenita - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Myotonia Congenita - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:35:13-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE8912CAE04072910000000003620195&amp;ncbi_session=CE8912CAE040E511_0866SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1355%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1355&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1355/&amp;ncbi_pagename=Myotonia Congenita - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8912CAE040E511_0866SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>